Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts

Abnormalities in a gene encoding a messenger RNA splicing enzyme were found in nearly two thirds of patients with myelodysplastic syndromes characterized by ring sideroblasts. Patients with mutations had improved survival as compared with those without mutations. The myelodysplastic syndromes are a...

Full description

Saved in:
Bibliographic Details
Published inThe New England journal of medicine Vol. 365; no. 15; pp. 1384 - 1395
Main Authors Papaemmanuil, E, Cazzola, M, Boultwood, J, Malcovati, L, Vyas, P, Bowen, D, Pellagatti, A, Wainscoat, J.S, Hellstrom-Lindberg, E, Gambacorti-Passerini, C, Godfrey, A.L, Rapado, I, Cvejic, A, Rance, R, McGee, C, Ellis, P, Mudie, L.J, Stephens, P.J, McLaren, S, Massie, C.E, Tarpey, P.S, Varela, I, Nik-Zainal, S, Davies, H.R, Shlien, A, Jones, D, Raine, K, Hinton, J, Butler, A.P, Teague, J.W, Baxter, E.J, Score, J, Galli, A, Della Porta, M.G, Travaglino, E, Groves, M, Tauro, S, Munshi, N.C, Anderson, K.C, El-Naggar, A, Fischer, A, Mustonen, V, Warren, A.J, Cross, N.C.P, Green, A.R, Futreal, P.A, Stratton, M.R, Campbell, P.J
Format Journal Article
LanguageEnglish
Published Waltham, MA Massachusetts Medical Society 13.10.2011
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Abnormalities in a gene encoding a messenger RNA splicing enzyme were found in nearly two thirds of patients with myelodysplastic syndromes characterized by ring sideroblasts. Patients with mutations had improved survival as compared with those without mutations. The myelodysplastic syndromes are a heterogeneous group of hematologic cancers characterized by low blood counts, most commonly anemia, and a risk of progression to acute myeloid leukemia. 1 These disorders have increased in prevalence and are expected to continue to do so. Blood films and bone marrow–biopsy specimens from patients with myelodysplastic syndromes show dysplastic changes in myeloid cells, with abnormal proliferation and differentiation of one or more lineages. Target genes of recurrent chromosomal aberrations have been mapped, 2 , 3 and several genes have been identified as recurrently mutated in these disorders, including NRAS (encoding neuroblastoma RAS viral oncogene homologue), TP53 (encoding . . .
AbstractList BACKGROUNDMyelodysplastic syndromes are a diverse and common group of chronic hematologic cancers. The identification of new genetic lesions could facilitate new diagnostic and therapeutic strategies. METHODSWe used massively parallel sequencing technology to identify somatically acquired point mutations across all protein-coding exons in the genome in 9 patients with low-grade myelodysplasia. Targeted resequencing of the gene encoding RNA splicing factor 3B, subunit 1 (SF3B1), was also performed in a cohort of 2087 patients with myeloid or other cancers. RESULTSWe identified 64 point mutations in the 9 patients. Recurrent somatically acquired mutations were identified in SF3B1. Follow-up revealed SF3B1 mutations in 72 of 354 patients (20%) with myelodysplastic syndromes, with particularly high frequency among patients whose disease was characterized by ring sideroblasts (53 of 82 [65%]). The gene was also mutated in 1 to 5% of patients with a variety of other tumor types. The observed mutations were less deleterious than was expected on the basis of chance, suggesting that the mutated protein retains structural integrity with altered function. SF3B1 mutations were associated with down-regulation of key gene networks, including core mitochondrial pathways. Clinically, patients with SF3B1 mutations had fewer cytopenias and longer event-free survival than patients without SF3B1 mutations. CONCLUSIONSMutations in SF3B1 implicate abnormalities of messenger RNA splicing in the pathogenesis of myelodysplastic syndromes. (Funded by the Wellcome Trust and others.).
Abnormalities in a gene encoding a messenger RNA splicing enzyme were found in nearly two thirds of patients with myelodysplastic syndromes characterized by ring sideroblasts. Patients with mutations had improved survival as compared with those without mutations. The myelodysplastic syndromes are a heterogeneous group of hematologic cancers characterized by low blood counts, most commonly anemia, and a risk of progression to acute myeloid leukemia. 1 These disorders have increased in prevalence and are expected to continue to do so. Blood films and bone marrow–biopsy specimens from patients with myelodysplastic syndromes show dysplastic changes in myeloid cells, with abnormal proliferation and differentiation of one or more lineages. Target genes of recurrent chromosomal aberrations have been mapped, 2 , 3 and several genes have been identified as recurrently mutated in these disorders, including NRAS (encoding neuroblastoma RAS viral oncogene homologue), TP53 (encoding . . .
Myelodysplastic syndromes are a diverse and common group of chronic hematologic cancers. The identification of new genetic lesions could facilitate new diagnostic and therapeutic strategies. We used massively parallel sequencing technology to identify somatically acquired point mutations across all protein-coding exons in the genome in 9 patients with low-grade myelodysplasia. Targeted resequencing of the gene encoding RNA splicing factor 3B, subunit 1 (SF3B1), was also performed in a cohort of 2087 patients with myeloid or other cancers. We identified 64 point mutations in the 9 patients. Recurrent somatically acquired mutations were identified in SF3B1. Follow-up revealed SF3B1 mutations in 72 of 354 patients (20%) with myelodysplastic syndromes, with particularly high frequency among patients whose disease was characterized by ring sideroblasts (53 of 82 [65%]). The gene was also mutated in 1 to 5% of patients with a variety of other tumor types. The observed mutations were less deleterious than was expected on the basis of chance, suggesting that the mutated protein retains structural integrity with altered function. SF3B1 mutations were associated with down-regulation of key gene networks, including core mitochondrial pathways. Clinically, patients with SF3B1 mutations had fewer cytopenias and longer event-free survival than patients without SF3B1 mutations. Mutations in SF3B1 implicate abnormalities of messenger RNA splicing in the pathogenesis of myelodysplastic syndromes. (Funded by the Wellcome Trust and others.).
Author Raine, K
McLaren, S
Teague, J.W
El-Naggar, A
Pellagatti, A
Hellstrom-Lindberg, E
Cazzola, M
Tarpey, P.S
Tauro, S
Travaglino, E
Score, J
Groves, M
Varela, I
Wainscoat, J.S
Cross, N.C.P
Della Porta, M.G
Papaemmanuil, E
McGee, C
Ellis, P
Hinton, J
Fischer, A
Campbell, P.J
Baxter, E.J
Green, A.R
Rapado, I
Cvejic, A
Nik-Zainal, S
Galli, A
Warren, A.J
Shlien, A
Mudie, L.J
Stephens, P.J
Bowen, D
Rance, R
Malcovati, L
Massie, C.E
Anderson, K.C
Davies, H.R
Butler, A.P
Munshi, N.C
Vyas, P
Jones, D
Mustonen, V
Stratton, M.R
Godfrey, A.L
Boultwood, J
Gambacorti-Passerini, C
Futreal, P.A
Author_xml – sequence: 1
  givenname: E
  surname: Papaemmanuil
  fullname: Papaemmanuil, E
– sequence: 2
  givenname: M
  surname: Cazzola
  fullname: Cazzola, M
– sequence: 3
  givenname: J
  surname: Boultwood
  fullname: Boultwood, J
– sequence: 4
  givenname: L
  surname: Malcovati
  fullname: Malcovati, L
– sequence: 5
  givenname: P
  surname: Vyas
  fullname: Vyas, P
– sequence: 6
  givenname: D
  surname: Bowen
  fullname: Bowen, D
– sequence: 7
  givenname: A
  surname: Pellagatti
  fullname: Pellagatti, A
– sequence: 8
  givenname: J.S
  surname: Wainscoat
  fullname: Wainscoat, J.S
– sequence: 9
  givenname: E
  surname: Hellstrom-Lindberg
  fullname: Hellstrom-Lindberg, E
– sequence: 10
  givenname: C
  surname: Gambacorti-Passerini
  fullname: Gambacorti-Passerini, C
– sequence: 11
  givenname: A.L
  surname: Godfrey
  fullname: Godfrey, A.L
– sequence: 12
  givenname: I
  surname: Rapado
  fullname: Rapado, I
– sequence: 13
  givenname: A
  surname: Cvejic
  fullname: Cvejic, A
– sequence: 14
  givenname: R
  surname: Rance
  fullname: Rance, R
– sequence: 15
  givenname: C
  surname: McGee
  fullname: McGee, C
– sequence: 16
  givenname: P
  surname: Ellis
  fullname: Ellis, P
– sequence: 17
  givenname: L.J
  surname: Mudie
  fullname: Mudie, L.J
– sequence: 18
  givenname: P.J
  surname: Stephens
  fullname: Stephens, P.J
– sequence: 19
  givenname: S
  surname: McLaren
  fullname: McLaren, S
– sequence: 20
  givenname: C.E
  surname: Massie
  fullname: Massie, C.E
– sequence: 21
  givenname: P.S
  surname: Tarpey
  fullname: Tarpey, P.S
– sequence: 22
  givenname: I
  surname: Varela
  fullname: Varela, I
– sequence: 23
  givenname: S
  surname: Nik-Zainal
  fullname: Nik-Zainal, S
– sequence: 24
  givenname: H.R
  surname: Davies
  fullname: Davies, H.R
– sequence: 25
  givenname: A
  surname: Shlien
  fullname: Shlien, A
– sequence: 26
  givenname: D
  surname: Jones
  fullname: Jones, D
– sequence: 27
  givenname: K
  surname: Raine
  fullname: Raine, K
– sequence: 28
  givenname: J
  surname: Hinton
  fullname: Hinton, J
– sequence: 29
  givenname: A.P
  surname: Butler
  fullname: Butler, A.P
– sequence: 30
  givenname: J.W
  surname: Teague
  fullname: Teague, J.W
– sequence: 31
  givenname: E.J
  surname: Baxter
  fullname: Baxter, E.J
– sequence: 32
  givenname: J
  surname: Score
  fullname: Score, J
– sequence: 33
  givenname: A
  surname: Galli
  fullname: Galli, A
– sequence: 34
  givenname: M.G
  surname: Della Porta
  fullname: Della Porta, M.G
– sequence: 35
  givenname: E
  surname: Travaglino
  fullname: Travaglino, E
– sequence: 36
  givenname: M
  surname: Groves
  fullname: Groves, M
– sequence: 37
  givenname: S
  surname: Tauro
  fullname: Tauro, S
– sequence: 38
  givenname: N.C
  surname: Munshi
  fullname: Munshi, N.C
– sequence: 39
  givenname: K.C
  surname: Anderson
  fullname: Anderson, K.C
– sequence: 40
  givenname: A
  surname: El-Naggar
  fullname: El-Naggar, A
– sequence: 41
  givenname: A
  surname: Fischer
  fullname: Fischer, A
– sequence: 42
  givenname: V
  surname: Mustonen
  fullname: Mustonen, V
– sequence: 43
  givenname: A.J
  surname: Warren
  fullname: Warren, A.J
– sequence: 44
  givenname: N.C.P
  surname: Cross
  fullname: Cross, N.C.P
– sequence: 45
  givenname: A.R
  surname: Green
  fullname: Green, A.R
– sequence: 46
  givenname: P.A
  surname: Futreal
  fullname: Futreal, P.A
– sequence: 47
  givenname: M.R
  surname: Stratton
  fullname: Stratton, M.R
– sequence: 48
  givenname: P.J
  surname: Campbell
  fullname: Campbell, P.J
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24615731$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/21995386$$D View this record in MEDLINE/PubMed
http://kipublications.ki.se/Default.aspx?queryparsed=id:123398500$$DView record from Swedish Publication Index
BookMark eNp1kk1vEzEQhi3UiqaFI1e0QkKclvp77QsIqhZaNSAROFuOd9I67NrB3m2Vf1-jpg1Bqi-2x887fj2eQ7QXYgCEXhH8nmAhj7-dXkyjJQQzqtgzNCGCsZpzLPfQBGOqat5odoAOc17iMgjXz9EBJVoLpuQEfZzF3g7eVbMz9plU03EouxgqH6rpGrrYrvOqs9nb6tYP19UPH66qmW8hxXkJD_kF2l_YLsPLzXyEfp2d_jz5Wl9-_3J-8umydoLSoQZLMAbXUCuBSEY0aAuacWi5FMpRLCmRCnOqlZN4LltQws6LfdVoDAvHjlB9nzffwmqcm1XyvU1rE603m9DvsgIjOGGiKbx-kl-l2G5FD0JCGdNKYFy0H-61BeihdRCGZLvdFDsnwV-bq3hjGKNUKF0SvNskSPHPCHkwvc8Ous4GiGM2Gpf3So55Id_8Ry7jmEKppFHFDGmKoe3bXYo5J1g8WiHY_G0Cs9MEhX_9r_9H-uHXC_B2A9jsbLdINjiftxyXpJSQbLm-zybAsn_iwjsqTMcd
CODEN NEJMAG
CitedBy_id crossref_primary_10_1016_j_molmed_2012_06_006
crossref_primary_10_1038_leu_2013_58
crossref_primary_10_1038_nm_4165
crossref_primary_10_1200_JCO_2015_66_0118
crossref_primary_10_3390_diagnostics12071658
crossref_primary_10_1182_blood_2021015325
crossref_primary_10_1002_ajh_25950
crossref_primary_10_3892_etm_2017_4912
crossref_primary_10_1002_ajh_24867
crossref_primary_10_1016_j_clml_2017_02_015
crossref_primary_10_1016_j_jmoldx_2013_11_005
crossref_primary_10_1182_blood_2019000519
crossref_primary_10_1007_s12185_014_1670_3
crossref_primary_10_1182_blood_2018_10_839985
crossref_primary_10_1038_s41598_022_18921_2
crossref_primary_10_1016_j_med_2016_10_013
crossref_primary_10_1021_cb500697f
crossref_primary_10_1016_j_revmed_2012_09_015
crossref_primary_10_1080_17474086_2023_2206556
crossref_primary_10_1007_s00277_013_1915_x
crossref_primary_10_2169_naika_101_1994
crossref_primary_10_1182_blood_2011_12_395087
crossref_primary_10_1016_j_clml_2017_02_022
crossref_primary_10_1159_000354840
crossref_primary_10_1002_wrna_1178
crossref_primary_10_1038_nature14351
crossref_primary_10_1016_j_hoc_2014_04_008
crossref_primary_10_1038_leu_2013_336
crossref_primary_10_1016_j_htct_2018_10_006
crossref_primary_10_1101_cshperspect_a035535
crossref_primary_10_4103_IJPM_IJPM_484_16
crossref_primary_10_1101_gr_246678_118
crossref_primary_10_1038_s41375_019_0448_2
crossref_primary_10_1038_leu_2014_144
crossref_primary_10_5858_arpa_2014_0096_RA
crossref_primary_10_1016_j_leukres_2012_06_002
crossref_primary_10_3389_fonc_2022_905490
crossref_primary_10_1038_leu_2013_100
crossref_primary_10_1016_j_leukres_2012_07_019
crossref_primary_10_1586_ehm_12_58
crossref_primary_10_1093_jnci_djt257
crossref_primary_10_1158_2159_8290_CD_21_0508
crossref_primary_10_1182_asheducation_2013_1_504
crossref_primary_10_3389_fonc_2022_795955
crossref_primary_10_1053_j_seminhematol_2022_08_002
crossref_primary_10_1038_nrc3299
crossref_primary_10_1038_s41467_017_01590_5
crossref_primary_10_1038_onc_2012_347
crossref_primary_10_1007_s00277_017_3186_4
crossref_primary_10_1016_S1470_2045_17_30615_0
crossref_primary_10_1007_s13238_021_00856_5
crossref_primary_10_1038_s41573_019_0042_3
crossref_primary_10_3390_life13030604
crossref_primary_10_1586_ehm_12_67
crossref_primary_10_1016_j_trecan_2020_12_015
crossref_primary_10_1038_s41375_023_01857_5
crossref_primary_10_1007_s11899_019_00551_7
crossref_primary_10_1056_NEJMra1910138
crossref_primary_10_1158_1078_0432_CCR_13_0485
crossref_primary_10_1038_s41388_024_03036_x
crossref_primary_10_18632_oncotarget_749
crossref_primary_10_1038_s41375_020_1002_y
crossref_primary_10_1016_j_ccell_2018_07_003
crossref_primary_10_1038_s41408_018_0051_1
crossref_primary_10_1038_s41467_020_15171_6
crossref_primary_10_1016_j_modpat_2023_100397
crossref_primary_10_1182_blood_2016_03_643544
crossref_primary_10_3109_07853890_2014_898863
crossref_primary_10_1182_bloodadvances_2018022434
crossref_primary_10_1172_JCI138315
crossref_primary_10_1080_17460441_2022_2114452
crossref_primary_10_1200_JCO_2016_71_0806
crossref_primary_10_1007_s40291_012_0006_3
crossref_primary_10_1056_NEJMe1111584
crossref_primary_10_1261_rna_057919_116
crossref_primary_10_1002_ajh_22235
crossref_primary_10_1016_j_critrevonc_2018_03_020
crossref_primary_10_1038_leu_2014_331
crossref_primary_10_1016_j_clinbiochem_2013_01_023
crossref_primary_10_1038_leu_2014_330
crossref_primary_10_3390_ijms17060944
crossref_primary_10_18632_oncotarget_26564
crossref_primary_10_1126_science_1235122
crossref_primary_10_1016_j_jmoldx_2016_10_002
crossref_primary_10_1007_s11899_013_0180_3
crossref_primary_10_1182_blood_2013_12_542720
crossref_primary_10_1158_1541_7786_MCR_11_0462
crossref_primary_10_7554_eLife_44080
crossref_primary_10_1016_j_semcdb_2014_03_016
crossref_primary_10_1016_j_semcdb_2017_10_011
crossref_primary_10_1016_j_leukres_2012_08_011
crossref_primary_10_1016_j_leukres_2012_08_015
crossref_primary_10_1182_blood_2016_09_740308
crossref_primary_10_15252_embr_201541116
crossref_primary_10_1080_17474086_2017_1380515
crossref_primary_10_1016_j_leukres_2022_106820
crossref_primary_10_3390_cancers12030723
crossref_primary_10_1016_j_semcancer_2015_04_009
crossref_primary_10_1182_blood_2013_06_460295
crossref_primary_10_1038_s41375_019_0457_1
crossref_primary_10_1038_leu_2013_22
crossref_primary_10_1111_bjh_13651
crossref_primary_10_1038_s41375_022_01718_7
crossref_primary_10_1182_blood_2011_12_400994
crossref_primary_10_3390_curroncol31050175
crossref_primary_10_1021_acs_jpclett_3c01402
crossref_primary_10_1016_j_path_2015_10_004
crossref_primary_10_18632_oncotarget_26584
crossref_primary_10_1007_s11864_013_0224_x
crossref_primary_10_1182_blood_2020004850
crossref_primary_10_1016_j_plabm_2020_e00154
crossref_primary_10_1002_ajh_23541
crossref_primary_10_1007_s11899_016_0350_1
crossref_primary_10_1016_j_clml_2020_03_005
crossref_primary_10_1016_j_pathol_2022_03_002
crossref_primary_10_1002_ajh_24637
crossref_primary_10_1039_C4MB00663A
crossref_primary_10_1182_blood_2015_08_663237
crossref_primary_10_3390_cancers16050997
crossref_primary_10_1021_acschembio_0c00965
crossref_primary_10_1038_leu_2017_17
crossref_primary_10_1002_ajh_23373
crossref_primary_10_3390_ijms17040440
crossref_primary_10_1016_j_molcel_2012_01_026
crossref_primary_10_1097_MOH_0b013e328364f547
crossref_primary_10_3390_life12081135
crossref_primary_10_1002_ijc_28011
crossref_primary_10_1007_s00108_014_3598_3
crossref_primary_10_1038_bcj_2012_36
crossref_primary_10_1097_PAS_0000000000001166
crossref_primary_10_1158_2643_3230_BCD_21_0220
crossref_primary_10_3390_cancers14194681
crossref_primary_10_3109_10428194_2014_995648
crossref_primary_10_1111_bjh_12316
crossref_primary_10_1182_blood_2012_09_399725
crossref_primary_10_1016_j_leukres_2012_08_007
crossref_primary_10_1038_leu_2012_344
crossref_primary_10_1016_j_leukres_2012_08_008
crossref_primary_10_1016_j_leukres_2012_08_009
crossref_primary_10_1080_16078454_2020_1790840
crossref_primary_10_3390_ijms24055018
crossref_primary_10_1016_S2352_3026_20_30209_X
crossref_primary_10_1097_MOH_0000000000000632
crossref_primary_10_1016_j_molcel_2016_04_011
crossref_primary_10_1002_gcc_22510
crossref_primary_10_1007_s11899_014_0224_3
crossref_primary_10_1172_JCI125022
crossref_primary_10_1182_blood_2016_10_692400
crossref_primary_10_1038_s41587_022_01224_2
crossref_primary_10_1016_j_cell_2013_03_002
crossref_primary_10_1038_s41467_019_13001_y
crossref_primary_10_1097_MOH_0000000000000661
crossref_primary_10_1186_s13148_018_0476_1
crossref_primary_10_18632_oncotarget_7000
crossref_primary_10_1126_science_1253462
crossref_primary_10_1111_cts_12972
crossref_primary_10_14694_EdBook_AM_2013_33_388
crossref_primary_10_1016_j_leukres_2012_09_021
crossref_primary_10_18632_oncotarget_19628
crossref_primary_10_1038_s41375_019_0479_8
crossref_primary_10_1128_JVI_02049_20
crossref_primary_10_1182_hematology_2021000276
crossref_primary_10_1016_j_jmoldx_2018_07_002
crossref_primary_10_1182_blood_2013_05_504308
crossref_primary_10_1111_bjh_13610
crossref_primary_10_1182_blood_2012_02_412296
crossref_primary_10_1007_s00277_012_1457_7
crossref_primary_10_1021_acschembio_6b00562
crossref_primary_10_1182_blood_2013_01_480970
crossref_primary_10_1016_j_hemonc_2016_04_003
crossref_primary_10_1158_1541_7786_MCR_12_0695
crossref_primary_10_1038_s41375_023_01899_9
crossref_primary_10_1182_asheducation_2015_1_19
crossref_primary_10_1038_s41577_019_0195_7
crossref_primary_10_1038_leu_2014_161
crossref_primary_10_1016_j_leukres_2017_09_001
crossref_primary_10_1182_blood_2014_04_566752
crossref_primary_10_1016_j_clml_2022_08_012
crossref_primary_10_1182_blood_2012_11_469619
crossref_primary_10_1038_leu_2013_91
crossref_primary_10_1182_blood_2021012652
crossref_primary_10_1002_gcc_22784
crossref_primary_10_1093_bfgp_elv047
crossref_primary_10_1038_nrg3539
crossref_primary_10_1111_ejh_14115
crossref_primary_10_1038_leu_2013_120
crossref_primary_10_18632_oncotarget_19871
crossref_primary_10_1002_ajh_24253
crossref_primary_10_1038_leu_2013_88
crossref_primary_10_1038_s41375_021_01486_w
crossref_primary_10_1038_leu_2014_170
crossref_primary_10_1016_j_drudis_2012_07_013
crossref_primary_10_1038_leu_2013_80
crossref_primary_10_1111_cas_14424
crossref_primary_10_1097_PPO_0000000000000654
crossref_primary_10_2147_JBM_S232644
crossref_primary_10_1371_journal_pone_0175523
crossref_primary_10_1038_bmt_2015_110
crossref_primary_10_1038_srep43113
crossref_primary_10_1038_ncomms14060
crossref_primary_10_1016_j_clml_2023_01_001
crossref_primary_10_1182_blood_2016_10_695981
crossref_primary_10_1038_s41375_020_01116_x
crossref_primary_10_1016_j_hoc_2019_11_004
crossref_primary_10_1016_j_blre_2012_08_002
crossref_primary_10_1038_leu_2015_55
crossref_primary_10_1097_CMR_0000000000000345
crossref_primary_10_1038_leu_2012_130
crossref_primary_10_3390_cancers11121844
crossref_primary_10_1039_C5NP00110B
crossref_primary_10_1038_s41467_023_44081_6
crossref_primary_10_1097_MD_0000000000015743
crossref_primary_10_1371_journal_pone_0036876
crossref_primary_10_1097_MOH_0000000000000211
crossref_primary_10_1080_17474086_2022_2029698
crossref_primary_10_1038_s41568_022_00541_7
crossref_primary_10_1101_cshperspect_a034876
crossref_primary_10_3390_genes12081144
crossref_primary_10_1016_j_leukres_2018_02_004
crossref_primary_10_3389_fimmu_2024_1386993
crossref_primary_10_1016_j_clml_2016_08_005
crossref_primary_10_1038_ncomms4644
crossref_primary_10_1038_leu_2013_155
crossref_primary_10_1038_leu_2011_321
crossref_primary_10_1007_s12185_022_03317_9
crossref_primary_10_1093_jjco_hys206
crossref_primary_10_1159_000443906
crossref_primary_10_1007_s00761_012_2337_4
crossref_primary_10_3390_cancers13040841
crossref_primary_10_1515_cclm_2015_0789
crossref_primary_10_1016_j_critrevonc_2018_07_013
crossref_primary_10_1073_pnas_1812669115
crossref_primary_10_1200_EDBK_320113
crossref_primary_10_1111_cas_12614
crossref_primary_10_1007_s10637_013_0046_5
crossref_primary_10_1200_JCO_2013_52_3381
crossref_primary_10_1016_j_clml_2024_05_007
crossref_primary_10_1016_j_ccr_2014_03_036
crossref_primary_10_1111_bjh_12957
crossref_primary_10_1155_2017_3625946
crossref_primary_10_1016_j_stemcr_2018_03_020
crossref_primary_10_1182_blood_2012_10_461491
crossref_primary_10_2217_pme_13_33
crossref_primary_10_1101_gr_152132_112
crossref_primary_10_1182_blood_2014_07_591529
crossref_primary_10_1111_bjh_18240
crossref_primary_10_1083_jcb_201510032
crossref_primary_10_1158_2159_8290_CD_19_1330
crossref_primary_10_1038_srep42504
crossref_primary_10_1038_s41571_020_0350_x
crossref_primary_10_1016_j_ccell_2018_10_003
crossref_primary_10_1371_journal_pone_0079118
crossref_primary_10_1016_j_beha_2020_101189
crossref_primary_10_1111_j_1751_553X_2011_01390_x
crossref_primary_10_1016_j_clml_2022_01_002
crossref_primary_10_1182_blood_2012_05_429282
crossref_primary_10_1182_blood_2017_01_763425
crossref_primary_10_1080_10428194_2016_1246725
crossref_primary_10_1182_bloodadvances_2021004556
crossref_primary_10_1261_rna_056101_116
crossref_primary_10_1371_journal_pgen_1008464
crossref_primary_10_1097_HS9_0000000000000868
crossref_primary_10_1002_wrna_1501
crossref_primary_10_3390_cells9081901
crossref_primary_10_1111_j_1365_2141_2012_09158_x
crossref_primary_10_1016_j_hoc_2019_10_003
crossref_primary_10_1016_j_molcel_2024_04_006
crossref_primary_10_3390_ijms18020308
crossref_primary_10_1146_annurev_med_060712_200152
crossref_primary_10_1007_s00277_020_04360_4
crossref_primary_10_1182_blood_2012_06_440347
crossref_primary_10_18632_oncotarget_22983
crossref_primary_10_1186_s12920_021_01145_0
crossref_primary_10_1016_j_exphem_2018_11_001
crossref_primary_10_1007_s00432_016_2331_0
crossref_primary_10_1152_physiolgenomics_00120_2015
crossref_primary_10_1097_HS9_0000000000000635
crossref_primary_10_1182_blood_2015_07_604496
crossref_primary_10_18632_oncotarget_481
crossref_primary_10_1016_S0140_6736_23_00874_7
crossref_primary_10_1007_s11899_017_0405_y
crossref_primary_10_18632_oncotarget_10526
crossref_primary_10_1002_jha2_317
crossref_primary_10_1182_blood_2017_03_776070
crossref_primary_10_1080_10428194_2020_1839647
crossref_primary_10_1182_bloodadvances_2019000677
crossref_primary_10_1186_s12885_021_08427_x
crossref_primary_10_1200_JCO_2016_67_3616
crossref_primary_10_1016_j_critrevonc_2013_06_004
crossref_primary_10_1093_bioinformatics_btt750
crossref_primary_10_1093_narcan_zcad013
crossref_primary_10_1038_nrm4010
crossref_primary_10_1182_blood_2015_08_667063
crossref_primary_10_1159_000488712
crossref_primary_10_1007_s11899_015_0256_3
crossref_primary_10_1182_blood_2013_02_427641
crossref_primary_10_1182_blood_2017_02_692715
crossref_primary_10_1182_bloodadvances_2021006325
crossref_primary_10_1038_s41375_024_02262_2
crossref_primary_10_1155_2013_153634
crossref_primary_10_3109_10428194_2015_1037756
crossref_primary_10_1038_ng_1045
crossref_primary_10_1007_s12185_015_1747_7
crossref_primary_10_1007_s12185_012_1235_2
crossref_primary_10_1126_scitranslmed_aav5467
crossref_primary_10_1002_hon_3125
crossref_primary_10_1136_jclinpath_2019_205895
crossref_primary_10_1007_s12185_018_2551_y
crossref_primary_10_1056_NEJMoa1312542
crossref_primary_10_1038_onc_2013_520
crossref_primary_10_1038_ni_3517
crossref_primary_10_1261_rna_079585_123
crossref_primary_10_1038_s41375_019_0560_3
crossref_primary_10_1200_JCO_2011_40_7379
crossref_primary_10_1111_ejh_13092
crossref_primary_10_1038_nrc_2016_51
crossref_primary_10_1038_ng_1032
crossref_primary_10_1002_path_4337
crossref_primary_10_1038_s41588_020_00710_0
crossref_primary_10_1093_nar_gky946
crossref_primary_10_1038_nrd3823
crossref_primary_10_1158_1078_0432_CCR_16_2020
crossref_primary_10_1016_j_molcel_2017_12_029
crossref_primary_10_1172_JCI67201
crossref_primary_10_1016_j_mrrev_2016_07_011
crossref_primary_10_1182_bloodadvances_2017007062
crossref_primary_10_1038_s41467_016_0008_7
crossref_primary_10_1038_s41598_021_96585_0
crossref_primary_10_1158_0008_5472_CAN_17_3970
crossref_primary_10_1007_s12094_012_0922_z
crossref_primary_10_1586_17474086_2013_840997
crossref_primary_10_3390_cancers14122984
crossref_primary_10_1111_bjh_16249
crossref_primary_10_1186_s13148_021_01157_8
crossref_primary_10_3390_cancers13164116
crossref_primary_10_1080_10428194_2020_1719089
crossref_primary_10_5507_bp_2013_084
crossref_primary_10_3892_ol_2018_9079
crossref_primary_10_1038_s41598_019_55540_w
crossref_primary_10_1038_s41409_021_01446_z
crossref_primary_10_1038_leu_2016_251
crossref_primary_10_1371_journal_pgen_1004288
crossref_primary_10_1182_blood_2013_02_453068
crossref_primary_10_1093_ajcp_aqab010
crossref_primary_10_1182_blood_2018_04_845602
crossref_primary_10_1074_jbc_M117_813527
crossref_primary_10_1146_annurev_pathol_011811_132436
crossref_primary_10_1016_j_ccell_2016_08_006
crossref_primary_10_1182_blood_2012_05_429696
crossref_primary_10_1182_blood_2020005719
crossref_primary_10_1172_JCI141401
crossref_primary_10_1002_path_4129
crossref_primary_10_1093_nar_gkae185
crossref_primary_10_3389_fonc_2017_00297
crossref_primary_10_1182_blood_2019003654
crossref_primary_10_1038_s41392_021_00486_7
crossref_primary_10_1016_j_critrevonc_2014_01_006
crossref_primary_10_1038_ng_1031
crossref_primary_10_1056_NEJMoa1408617
crossref_primary_10_1517_13543784_2012_721352
crossref_primary_10_2169_internalmedicine_4214_19
crossref_primary_10_1111_ijlh_12981
crossref_primary_10_1146_annurev_genom_091212_153429
crossref_primary_10_18632_oncotarget_24538
crossref_primary_10_1056_NEJMra1904794
crossref_primary_10_1016_j_critrevonc_2017_12_013
crossref_primary_10_1111_bjh_16212
crossref_primary_10_1016_j_beha_2019_101132
crossref_primary_10_1038_nrc_2016_112
crossref_primary_10_1016_j_leukres_2012_04_003
crossref_primary_10_1016_j_leukres_2012_04_004
crossref_primary_10_1016_j_jbior_2016_08_001
crossref_primary_10_1016_j_beha_2019_101139
crossref_primary_10_12688_f1000research_15442_1
crossref_primary_10_14694_EdBook_AM_2015_35_e398
crossref_primary_10_1016_j_jbior_2013_09_005
crossref_primary_10_3390_ijms22063135
crossref_primary_10_1182_blood_2015_11_679167
crossref_primary_10_5045_br_2014_49_4_216
crossref_primary_10_1200_JCO_2012_45_5626
crossref_primary_10_1016_j_blre_2023_101072
crossref_primary_10_1002_cyto_b_22057
crossref_primary_10_1371_journal_pone_0050324
crossref_primary_10_3109_10428194_2013_790542
crossref_primary_10_1111_trf_16884
crossref_primary_10_1016_j_jbior_2023_100993
crossref_primary_10_3390_cancers12030652
crossref_primary_10_1182_blood_2018884338
crossref_primary_10_1016_j_critrevonc_2015_11_017
crossref_primary_10_1182_bloodadvances_2019001127
crossref_primary_10_3390_biology12010013
crossref_primary_10_1002_wrna_1527
crossref_primary_10_1038_bcj_2016_5
crossref_primary_10_1002_wrna_1760
crossref_primary_10_1146_annurev_cancerbio_030617_050407
crossref_primary_10_1002_ajh_23734
crossref_primary_10_1007_s11899_016_0342_1
crossref_primary_10_1016_j_drup_2020_100728
crossref_primary_10_2974_kmj_70_315
crossref_primary_10_1016_j_blre_2018_04_008
crossref_primary_10_1182_bloodadvances_2018024216
crossref_primary_10_1002_ijc_27896
crossref_primary_10_1016_j_prp_2014_02_006
crossref_primary_10_1016_j_stem_2014_03_002
crossref_primary_10_1182_blood_2011_09_377275
crossref_primary_10_1016_j_leukres_2012_06_013
crossref_primary_10_1038_s41375_018_0119_8
crossref_primary_10_1016_j_trsl_2017_05_001
crossref_primary_10_3390_jcm10102052
crossref_primary_10_1182_blood_2013_12_542209
crossref_primary_10_1007_s10637_019_00796_2
crossref_primary_10_1038_ng_2523
crossref_primary_10_3390_jcm11164908
crossref_primary_10_1016_j_blre_2015_09_001
crossref_primary_10_1080_10428194_2022_2095629
crossref_primary_10_1016_j_bbmt_2012_11_010
crossref_primary_10_1182_blood_2018_08_867333
crossref_primary_10_1097_CCO_0000000000000229
crossref_primary_10_1016_j_clml_2020_01_005
crossref_primary_10_1172_JCI91363
crossref_primary_10_1080_17474086_2017_1297704
crossref_primary_10_1182_blood_2020006868
crossref_primary_10_1097_HS9_0000000000000821
crossref_primary_10_1016_j_leukres_2012_05_007
crossref_primary_10_1101_gad_349368_122
crossref_primary_10_1182_bloodadvances_2018027714
crossref_primary_10_7759_cureus_30275
crossref_primary_10_1182_blood_2016_12_754796
crossref_primary_10_1007_s11899_016_0344_z
crossref_primary_10_1007_s10565_024_09859_4
crossref_primary_10_1101_gad_278424_116
crossref_primary_10_1038_s41467_018_06063_x
crossref_primary_10_3389_fonc_2020_579221
crossref_primary_10_1111_ijlh_13802
crossref_primary_10_1038_s41525_022_00292_2
crossref_primary_10_1007_s12015_020_10065_y
crossref_primary_10_1182_blood_2014_03_560227
crossref_primary_10_1182_blood_2018_08_815951
crossref_primary_10_1038_nature11143
crossref_primary_10_1002_wrna_1312
crossref_primary_10_1371_journal_pone_0166245
crossref_primary_10_1182_bloodadvances_2019001323
crossref_primary_10_1373_clinchem_2012_184713
crossref_primary_10_1111_bjh_14215
crossref_primary_10_1182_blood_2012_03_420489
crossref_primary_10_1038_s41388_018_0524_5
crossref_primary_10_1016_S0140_6736_13_61901_7
crossref_primary_10_1038_s41375_021_01328_9
crossref_primary_10_1016_j_semcancer_2017_10_011
crossref_primary_10_2183_pjab_96_009
crossref_primary_10_3109_10428194_2013_856427
crossref_primary_10_1038_leu_2012_86
crossref_primary_10_1111_cas_15213
crossref_primary_10_1182_blood_2011_12_399337
crossref_primary_10_1097_MOH_0000000000000112
crossref_primary_10_1097_MOH_0000000000000110
crossref_primary_10_1016_j_mrrev_2016_04_009
crossref_primary_10_3390_cancers15235685
crossref_primary_10_1182_blood_2011_09_377994
crossref_primary_10_1111_j_1440_1827_2012_02855_x
crossref_primary_10_1002_ajh_23642
crossref_primary_10_1093_nargab_lqaa013
crossref_primary_10_1016_j_path_2016_04_010
crossref_primary_10_1016_j_csbj_2020_12_009
crossref_primary_10_1182_asheducation_2014_1_287
crossref_primary_10_1182_blood_2013_08_518886
crossref_primary_10_1038_leu_2014_49
crossref_primary_10_1038_leusup_2012_20
crossref_primary_10_1586_17474086_2016_1135047
crossref_primary_10_1182_blood_2012_05_430876
crossref_primary_10_1002_path_5060
crossref_primary_10_1111_cas_15476
crossref_primary_10_1038_s41375_020_0979_6
crossref_primary_10_1126_sciadv_adl4018
crossref_primary_10_1182_blood_2016_10_696062
crossref_primary_10_1172_JCI151627
crossref_primary_10_1261_rna_042259_113
crossref_primary_10_1038_nm_4493
crossref_primary_10_1038_ng_2508
crossref_primary_10_1073_pnas_1407688111
crossref_primary_10_1016_j_semcdb_2017_09_018
crossref_primary_10_1158_2159_8290_CD_13_0253
crossref_primary_10_1182_bloodadvances_2022007804
crossref_primary_10_1016_j_blre_2014_01_002
crossref_primary_10_1038_s41586_019_1646_9
crossref_primary_10_1016_j_clml_2017_09_018
crossref_primary_10_1007_s11899_012_0121_6
crossref_primary_10_1182_blood_2017_07_793075
crossref_primary_10_1038_s41375_022_01728_5
crossref_primary_10_1111_bjh_13563
crossref_primary_10_1016_j_leukres_2017_02_013
crossref_primary_10_2147_OTT_S286867
crossref_primary_10_1182_blood_2012_08_447094
crossref_primary_10_1182_blood_2021011045
crossref_primary_10_1002_ajh_23458
crossref_primary_10_1016_j_leukres_2017_10_015
crossref_primary_10_3390_jpm10030094
crossref_primary_10_1016_j_scr_2021_102195
crossref_primary_10_1053_j_seminhematol_2012_09_002
crossref_primary_10_1002_ajh_24306
crossref_primary_10_1136_jclinpath_2020_206495
crossref_primary_10_3390_cancers14153812
crossref_primary_10_1182_blood_2015_05_645713
crossref_primary_10_1016_j_canlet_2012_09_027
crossref_primary_10_1021_acschembio_9b01027
crossref_primary_10_1016_j_cell_2012_04_023
crossref_primary_10_1002_ajh_24776
crossref_primary_10_1373_clinchem_2013_204099
crossref_primary_10_1182_blood_2013_07_512855
crossref_primary_10_1158_0008_5472_CAN_14_2930
crossref_primary_10_3389_fonc_2024_1377974
crossref_primary_10_1111_ejh_12443
crossref_primary_10_3892_ol_2017_7334
crossref_primary_10_1002_iub_2660
crossref_primary_10_1111_bjh_12694
crossref_primary_10_1016_j_annonc_2022_03_011
crossref_primary_10_1074_jbc_M113_515536
crossref_primary_10_7554_eLife_23268
crossref_primary_10_1002_ajh_23675
crossref_primary_10_1038_s41375_022_01783_y
crossref_primary_10_1182_blood_2011_11_390252
crossref_primary_10_1200_EDBK_175397
crossref_primary_10_1016_j_clml_2016_02_031
crossref_primary_10_1002_bies_201300156
crossref_primary_10_1056_NEJMoa1114885
crossref_primary_10_1007_s12185_022_03291_2
crossref_primary_10_33590_emjhematol_10310896
crossref_primary_10_1016_j_bjhh_2016_08_003
crossref_primary_10_1016_j_semcancer_2020_10_015
crossref_primary_10_26508_lsa_202301955
crossref_primary_10_1038_s41375_019_0532_7
crossref_primary_10_1016_j_pathol_2021_01_005
crossref_primary_10_3389_fmolb_2021_726902
crossref_primary_10_1016_j_xgen_2022_100179
crossref_primary_10_1038_s43018_022_00384_z
crossref_primary_10_1016_j_bbagrm_2019_194440
crossref_primary_10_1172_JCI175619
crossref_primary_10_1016_j_tvjl_2015_10_051
crossref_primary_10_1200_JCO_20_01659
crossref_primary_10_1002_gcc_21960
crossref_primary_10_1182_blood_2016_07_692988
crossref_primary_10_1186_1471_2407_12_304
crossref_primary_10_1038_s41375_021_01176_7
crossref_primary_10_3390_ijms22157789
crossref_primary_10_1038_modpathol_2016_100
crossref_primary_10_1016_j_jmoldx_2022_05_003
crossref_primary_10_1038_leu_2014_7
crossref_primary_10_3390_jcm9030802
crossref_primary_10_1530_ERC_18_0068
crossref_primary_10_1111_bjh_12435
crossref_primary_10_1038_s41467_020_16052_8
crossref_primary_10_1002_ajh_24102
crossref_primary_10_1007_s13277_015_4305_2
crossref_primary_10_1093_jb_mvac049
crossref_primary_10_1016_j_blre_2016_11_001
crossref_primary_10_1200_EDBK_239083
crossref_primary_10_1016_j_ccell_2023_04_006
crossref_primary_10_1016_j_cll_2023_07_001
crossref_primary_10_1016_j_cll_2023_07_003
crossref_primary_10_1038_nrc_2017_60
crossref_primary_10_1016_j_jbior_2019_100673
crossref_primary_10_1111_bjh_14602
crossref_primary_10_1182_blood_2011_10_386540
crossref_primary_10_1038_s41598_023_29794_4
crossref_primary_10_1016_j_bjhh_2016_06_002
crossref_primary_10_1016_j_semcdb_2017_08_048
crossref_primary_10_1097_MOH_0000000000000752
crossref_primary_10_1073_pnas_2216712119
crossref_primary_10_1182_asheducation_2015_1_308
crossref_primary_10_3390_ijms241411412
crossref_primary_10_1038_bcj_2013_16
crossref_primary_10_1089_gtmb_2012_0364
crossref_primary_10_1016_j_chembiol_2021_03_002
crossref_primary_10_1093_nar_gkw1349
crossref_primary_10_47429_lmo_2021_11_1_40
crossref_primary_10_1038_s41568_020_00306_0
crossref_primary_10_1053_j_seminhematol_2015_06_002
crossref_primary_10_1097_HS9_0000000000000218
crossref_primary_10_1101_cshperspect_a034967
crossref_primary_10_1182_asheducation_2017_1_66
crossref_primary_10_1182_asheducation_2018_1_277
crossref_primary_10_1007_s11899_015_0270_5
crossref_primary_10_1038_s41375_020_0839_4
crossref_primary_10_1371_journal_pgen_1003855
crossref_primary_10_1016_j_molcel_2024_02_032
crossref_primary_10_18632_oncotarget_7127
crossref_primary_10_3390_ijms21249424
crossref_primary_10_1016_j_jbior_2020_100776
crossref_primary_10_1002_ajh_26984
crossref_primary_10_3390_cancers12082216
crossref_primary_10_1016_j_celrep_2021_108989
crossref_primary_10_1016_j_chembiol_2021_04_018
crossref_primary_10_7554_eLife_59654
crossref_primary_10_1016_j_bbrc_2021_01_084
crossref_primary_10_3109_10428194_2012_742528
crossref_primary_10_1038_nrc_2017_40
crossref_primary_10_1371_journal_pgen_1004932
crossref_primary_10_1182_blood_2020008215
crossref_primary_10_3389_fonc_2022_989483
crossref_primary_10_1016_j_cll_2021_03_015
crossref_primary_10_1016_j_path_2019_03_010
crossref_primary_10_1186_1746_1596_8_87
crossref_primary_10_1093_nar_gky1161
crossref_primary_10_1101_gad_312058_118
crossref_primary_10_1111_ijlh_12361
crossref_primary_10_1534_g3_117_300338
crossref_primary_10_15252_embj_201488244
crossref_primary_10_1097_MOH_0000000000000562
crossref_primary_10_1016_S1470_2045_14_70008_7
crossref_primary_10_1101_gad_291872_116
crossref_primary_10_1007_s11434_014_0692_9
crossref_primary_10_1038_s41375_018_0021_4
crossref_primary_10_3390_ijms21051551
crossref_primary_10_1016_j_leukres_2014_10_006
crossref_primary_10_1186_s13073_015_0168_9
crossref_primary_10_1002_mgg3_23
crossref_primary_10_1038_s41388_020_01507_5
crossref_primary_10_1186_s13045_015_0154_0
crossref_primary_10_1016_j_blre_2022_101033
crossref_primary_10_1111_bjh_12622
crossref_primary_10_3324_haematol_2020_260562
crossref_primary_10_3390_life11121351
crossref_primary_10_1182_asheducation_2015_1_349
crossref_primary_10_1177_2040620712458948
crossref_primary_10_2217_ijh_2021_0002
crossref_primary_10_1002_ajh_26799
crossref_primary_10_1016_j_blre_2022_101039
crossref_primary_10_1016_j_leukres_2014_04_015
crossref_primary_10_1146_annurev_pathol_012615_044454
crossref_primary_10_1097_MOH_0000000000000325
crossref_primary_10_1080_23808993_2016_1159510
crossref_primary_10_1016_j_tig_2014_07_005
crossref_primary_10_1016_j_blre_2022_101001
crossref_primary_10_5045_br_2021_2021010
crossref_primary_10_1007_s11899_014_0234_1
crossref_primary_10_3390_ijms20112718
crossref_primary_10_1038_bcj_2013_26
crossref_primary_10_1002_wcms_1643
crossref_primary_10_1016_j_lrr_2018_08_001
crossref_primary_10_1038_leu_2013_269
crossref_primary_10_1128_MCB_00202_15
crossref_primary_10_3390_ijms21197140
crossref_primary_10_1111_imr_12241
crossref_primary_10_1080_21678707_2019_1672534
crossref_primary_10_1038_leu_2013_263
crossref_primary_10_1016_j_tig_2017_03_001
crossref_primary_10_1038_leu_2014_73
crossref_primary_10_1038_s41588_018_0078_z
crossref_primary_10_1016_j_semcancer_2019_09_013
crossref_primary_10_3389_fonc_2022_1033534
crossref_primary_10_1007_s11912_021_01136_5
crossref_primary_10_1038_leu_2012_241
crossref_primary_10_1182_blood_2021014923
crossref_primary_10_3389_fgene_2019_00338
crossref_primary_10_1073_pnas_2111703119
crossref_primary_10_1016_j_jbior_2022_100920
crossref_primary_10_3390_genes8080201
crossref_primary_10_1186_gm524
crossref_primary_10_1016_j_pathog_2015_05_004
crossref_primary_10_1016_j_leukres_2017_01_031
crossref_primary_10_1016_j_leukres_2019_106227
crossref_primary_10_1182_blood_2015_03_631747
crossref_primary_10_1002_ajh_25397
crossref_primary_10_1016_j_stem_2023_07_012
crossref_primary_10_1016_j_tig_2012_01_001
crossref_primary_10_1038_ncomms3997
crossref_primary_10_1002_cncr_28552
crossref_primary_10_1186_s13045_014_0089_x
crossref_primary_10_1080_14728222_2018_1417390
crossref_primary_10_3389_fonc_2020_609409
crossref_primary_10_1038_onc_2016_279
crossref_primary_10_1182_bloodadvances_2017010165
crossref_primary_10_1093_jleuko_qiac015
crossref_primary_10_1016_j_molcel_2023_02_024
crossref_primary_10_1016_j_ceb_2018_02_011
crossref_primary_10_1038_s41556_019_0314_5
crossref_primary_10_1186_s13073_016_0311_2
crossref_primary_10_3390_ijms221910475
crossref_primary_10_1016_j_gde_2012_01_008
crossref_primary_10_1016_j_molmed_2021_06_013
crossref_primary_10_3390_ijms221910232
crossref_primary_10_1182_blood_2018_03_840132
crossref_primary_10_1371_journal_pone_0107817
crossref_primary_10_1038_s41375_020_0753_9
crossref_primary_10_1517_14656566_2014_937705
crossref_primary_10_1007_s11033_023_08597_w
crossref_primary_10_1200_JCO_2013_48_7447
crossref_primary_10_3390_cancers14225690
crossref_primary_10_1002_gcc_22689
crossref_primary_10_1007_s00761_012_2338_3
crossref_primary_10_1186_s13046_023_02858_z
crossref_primary_10_1074_jbc_M114_558825
crossref_primary_10_1182_asheducation_2015_1_299
crossref_primary_10_1038_leu_2012_298
crossref_primary_10_1002_ajmg_a_61238
crossref_primary_10_1016_j_jbi_2015_10_003
crossref_primary_10_1158_0008_5472_CAN_16_1303
crossref_primary_10_3390_cancers15010110
crossref_primary_10_1038_s41467_020_17917_8
crossref_primary_10_1158_2159_8290_CD_19_0399
crossref_primary_10_1182_blood_2012_03_415356
crossref_primary_10_1182_blood_2013_03_492884
crossref_primary_10_1182_blood_2023020649
crossref_primary_10_1111_bjh_16175
crossref_primary_10_1007_s00277_014_2252_4
crossref_primary_10_1186_s13045_018_0558_8
crossref_primary_10_1007_s12185_017_2242_0
crossref_primary_10_1016_j_clml_2021_07_031
crossref_primary_10_1007_s15004_012_0224_1
crossref_primary_10_1515_cclm_2016_0142
crossref_primary_10_1016_j_jmoldx_2019_10_002
crossref_primary_10_1002_ajh_24038
crossref_primary_10_1016_j_beha_2013_09_005
crossref_primary_10_1038_s41375_020_01106_z
crossref_primary_10_1093_narcan_zcac039
crossref_primary_10_1016_j_beha_2013_09_007
crossref_primary_10_1016_j_leukres_2013_04_013
crossref_primary_10_1186_1741_7015_11_124
crossref_primary_10_33590_emjoncol_10311896
crossref_primary_10_1016_j_leukres_2016_02_011
crossref_primary_10_1002_jha2_264
crossref_primary_10_1016_j_tig_2017_12_012
crossref_primary_10_1111_cas_12532
crossref_primary_10_1182_asheducation_V2012_1_56_3798194
crossref_primary_10_1016_j_ijbiomac_2019_02_012
crossref_primary_10_1186_s10020_024_00839_2
crossref_primary_10_1093_jb_mvab023
crossref_primary_10_1186_gm451
crossref_primary_10_1016_j_exphem_2024_104173
crossref_primary_10_58931_cht_2022_115
crossref_primary_10_1261_rna_047258_114
crossref_primary_10_3390_cancers13092120
crossref_primary_10_1053_j_seminhematol_2017_07_002
crossref_primary_10_1038_nrc_2017_23
crossref_primary_10_1051_medsci_20163212015
crossref_primary_10_1111_odi_13739
crossref_primary_10_1186_s13059_020_02240_8
crossref_primary_10_3390_ijms241411335
crossref_primary_10_1016_j_gde_2017_10_008
crossref_primary_10_1007_s00439_013_1411_3
crossref_primary_10_1097_HS9_0000000000000537
crossref_primary_10_1038_s41375_019_0617_3
crossref_primary_10_1080_14728214_2016_1220534
crossref_primary_10_1111_ggi_14026
crossref_primary_10_1158_0008_5472_CAN_23_3239
crossref_primary_10_1182_blood_2012_04_423046
crossref_primary_10_1097_MOH_0000000000000620
crossref_primary_10_1126_scitranslmed_abn5135
crossref_primary_10_1182_blood_2013_09_381665
crossref_primary_10_1182_blood_2019004260
crossref_primary_10_1155_2012_358518
crossref_primary_10_1053_j_seminhematol_2024_01_011
crossref_primary_10_3324_haematol_2020_248955
crossref_primary_10_1097_MOH_0000000000000629
crossref_primary_10_1016_j_heliyon_2024_e32729
crossref_primary_10_1371_journal_pone_0126555
crossref_primary_10_1101_gr_181016_114
crossref_primary_10_1016_j_beha_2014_11_005
crossref_primary_10_1111_cge_14259
crossref_primary_10_1016_j_molmed_2021_04_005
crossref_primary_10_1007_s12254_012_0036_x
crossref_primary_10_1155_2013_568931
crossref_primary_10_1007_s11899_016_0347_9
crossref_primary_10_1093_carcin_bgt247
crossref_primary_10_1182_bloodadvances_2019000518
crossref_primary_10_1016_j_exphem_2014_04_006
crossref_primary_10_3389_fonc_2021_769753
crossref_primary_10_3390_genes13091562
crossref_primary_10_1158_2159_8290_CD_19_1436
crossref_primary_10_1016_j_celrep_2021_109626
crossref_primary_10_1182_bloodadvances_2021006649
crossref_primary_10_1016_j_jbior_2019_100655
crossref_primary_10_1371_journal_pbio_1001809
crossref_primary_10_1158_1078_0432_CCR_12_1251
crossref_primary_10_1002_cmdc_202000642
crossref_primary_10_3390_cancers11071019
crossref_primary_10_1038_nrc3321
crossref_primary_10_7861_clinmedicine_14_6_s71
crossref_primary_10_1016_j_gde_2016_03_006
crossref_primary_10_4161_23723548_2014_970955
crossref_primary_10_1039_D3MD00685A
crossref_primary_10_1186_s12885_015_1493_5
crossref_primary_10_1158_1078_0432_CCR_23_0538
crossref_primary_10_1016_j_tig_2014_03_005
crossref_primary_10_2139_ssrn_2945010
crossref_primary_10_1016_j_lrr_2022_100334
crossref_primary_10_1002_cncr_33745
crossref_primary_10_1038_leu_2017_180
crossref_primary_10_1002_ajh_26090
crossref_primary_10_1038_leu_2017_184
crossref_primary_10_1016_j_celrep_2015_09_053
crossref_primary_10_1080_10428194_2021_1876860
crossref_primary_10_1038_ng_2696
crossref_primary_10_1053_j_seminhematol_2014_08_007
crossref_primary_10_1002_acg2_78
crossref_primary_10_1038_s41467_018_04760_1
crossref_primary_10_1101_gad_351154_123
crossref_primary_10_5402_2012_321246
crossref_primary_10_1111_bjh_14168
crossref_primary_10_1182_blood_2015_03_633537
crossref_primary_10_1182_blood_2018_04_843771
crossref_primary_10_1038_leu_2016_364
crossref_primary_10_1002_path_4483
crossref_primary_10_1053_j_seminhematol_2017_06_007
crossref_primary_10_1177_1087057113493117
crossref_primary_10_1080_10428194_2018_1520990
crossref_primary_10_1038_ng_2443
crossref_primary_10_1146_annurev_med_120811_171056
crossref_primary_10_1111_j_1755_148X_2012_00976_x
crossref_primary_10_1016_j_bbmt_2011_11_011
crossref_primary_10_1016_j_jbior_2017_09_008
crossref_primary_10_1038_leu_2014_303
crossref_primary_10_1146_annurev_pathmechdis_012419_032810
crossref_primary_10_1093_jb_mvv114
crossref_primary_10_1038_s41467_024_46547_7
crossref_primary_10_1038_leu_2016_149
crossref_primary_10_1002_wrna_1222
crossref_primary_10_1038_nature14985
crossref_primary_10_1007_s12308_015_0253_4
crossref_primary_10_1038_s41375_018_0173_2
crossref_primary_10_1182_blood_2011_12_401471
crossref_primary_10_1038_leu_2015_110
crossref_primary_10_36401_JIPO_22_1
crossref_primary_10_1016_j_omtn_2023_102042
crossref_primary_10_1074_jbc_RA118_001654
crossref_primary_10_1111_bjh_17414
crossref_primary_10_1016_j_path_2021_01_005
crossref_primary_10_1038_nm_4097
crossref_primary_10_1016_j_cancergen_2013_01_003
crossref_primary_10_1016_j_leukres_2018_08_022
crossref_primary_10_1002_wrna_1476
crossref_primary_10_1002_acg2_83
crossref_primary_10_1080_17474086_2020_1744433
crossref_primary_10_1158_0008_5472_CAN_21_1843
crossref_primary_10_1093_labmed_lmy070
crossref_primary_10_1007_s12185_011_0998_1
crossref_primary_10_1093_nar_gkt1388
crossref_primary_10_1038_leu_2017_172
crossref_primary_10_1007_s11899_016_0356_8
crossref_primary_10_1007_s12185_012_1182_y
crossref_primary_10_3390_cells10040923
crossref_primary_10_1093_ajcp_aqaa016
crossref_primary_10_1021_acs_chemrev_3c00062
crossref_primary_10_1016_j_molcel_2019_07_017
crossref_primary_10_1056_NEJMoa1409405
crossref_primary_10_3389_fmolb_2023_1273046
crossref_primary_10_1111_bjh_12194
crossref_primary_10_1038_ncomms10004
crossref_primary_10_1016_j_exphem_2016_05_012
crossref_primary_10_1182_blood_2011_12_399774
crossref_primary_10_1002_wrna_1643
crossref_primary_10_1016_j_clml_2015_03_017
crossref_primary_10_1038_ng_3742
crossref_primary_10_1182_blood_2014_04_522136
crossref_primary_10_1016_S0140_6736_23_01130_3
crossref_primary_10_1177_1010428317694318
crossref_primary_10_1080_17474086_2016_1233054
crossref_primary_10_1634_theoncologist_2014_0056
crossref_primary_10_1016_j_ebiom_2018_12_025
crossref_primary_10_1002_ajh_24930
crossref_primary_10_1038_s41467_018_08076_y
crossref_primary_10_1051_medsci_2012285002
crossref_primary_10_1016_j_celrep_2022_111825
crossref_primary_10_1021_acs_accounts_0c00578
crossref_primary_10_3390_ijms222011222
crossref_primary_10_3390_cancers13143380
crossref_primary_10_3389_fonc_2023_1152087
crossref_primary_10_3390_diagnostics11040600
crossref_primary_10_1016_j_ccell_2015_04_016
crossref_primary_10_1038_leu_2015_304
crossref_primary_10_1111_bjh_17621
crossref_primary_10_1111_ejh_12515
crossref_primary_10_15430_JCP_2017_22_4_203
crossref_primary_10_1182_blood_2015_04_640128
crossref_primary_10_1073_pnas_1500536112
crossref_primary_10_1038_modpathol_2016_179
crossref_primary_10_1016_j_ccell_2015_04_008
crossref_primary_10_1038_s41588_023_01460_5
crossref_primary_10_1016_j_ccell_2015_04_006
crossref_primary_10_1158_1078_0432_CCR_16_0131
crossref_primary_10_1080_10428194_2017_1307361
crossref_primary_10_1371_journal_pcbi_1004105
crossref_primary_10_1002_ijc_27791
crossref_primary_10_1186_s13046_022_02245_0
crossref_primary_10_1073_pnas_1922622117
crossref_primary_10_1371_journal_pgen_1009861
crossref_primary_10_2174_0929867326666190325100636
crossref_primary_10_1182_blood_2018_10_844621
crossref_primary_10_1158_2159_8290_CD_23_0282
Cites_doi 10.1056/NEJMra0902908
10.1056/NEJMoa0810069
10.1038/nature05610
10.1371/journal.pone.0001970
10.1073/pnas.0801523105
10.1073/pnas.0506580102
10.1038/ng.391
10.1182/blood-2005-12-4769
10.1038/nature09639
10.1073/pnas.0610477104
10.1182/blood-2009-03-209262
10.1038/nature09650
10.1038/leu.2010.20
10.1038/nature09733
10.1126/science.1164368
10.1182/blood-2004-12-4649
10.1053/j.seminhematol.2009.07.001
10.1126/science.1084155
10.1016/j.molcel.2005.02.016
10.1038/nature09460
10.1534/genetics.111.127480
10.1101/gad.12.10.1409
10.1038/nature06494
10.1038/nature08240
10.1056/NEJMoa1005143
10.1038/ng.621
10.1200/JCO.2005.01.7038
10.1038/bcj.2011.7
10.1038/nature08768
10.1182/blood-2008-12-194548
10.1038/leu.2011.44
10.1038/nature08989
10.1016/j.leukres.2005.11.015
10.1038/nrm2777
10.1111/j.1365-2141.2009.07697.x
10.1038/nature09837
10.1093/nar/gkp985
10.1038/leu.2010.31
ContentType Journal Article
Copyright Copyright © 2011 Massachusetts Medical Society. All rights reserved.
2015 INIST-CNRS
Copyright © 2011 Massachusetts Medical Society. All rights reserved. 2011
Copyright_xml – notice: Copyright © 2011 Massachusetts Medical Society. All rights reserved.
– notice: 2015 INIST-CNRS
– notice: Copyright © 2011 Massachusetts Medical Society. All rights reserved. 2011
CorporateAuthor Chronic Myeloid Disorders Working Group of the International Cancer Genome Consortium
CorporateAuthor_xml – name: Chronic Myeloid Disorders Working Group of the International Cancer Genome Consortium
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
0TZ
7RV
7X7
7XB
8AO
8C1
8FE
8FH
8FI
ABUWG
AFKRA
AN0
AZQEC
BBNVY
BEC
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
HCIFZ
K0Y
LK8
M0R
M0T
M1P
M2M
M2O
M2P
M7P
MBDVC
NAPCQ
PQEST
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7X8
5PM
ADTPV
AOWAS
D8T
ZZAVC
DOI 10.1056/NEJMoa1103283
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Pharma and Biotech Premium PRO
Nursing & Allied Health Database
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
ProQuest Pharma Collection
Public Health Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
ProQuest Central (Alumni Edition)
ProQuest Central UK/Ireland
British Nursing Database
ProQuest Central Essentials
Biological Science Collection
eLibrary
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
SciTech Premium Collection
New England Journal of Medicine
ProQuest Biological Science Collection
Consumer Health Database
Healthcare Administration Database
Medical Database
Psychology Database
ProQuest research library
Science Database
Biological Science Database
Research Library (Corporate)
Nursing & Allied Health Premium
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
SwePub
SwePub Articles
SWEPUB Freely available online
SwePub Articles full text
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
ProQuest One Psychology
Pharma and Biotech Premium PRO
Research Library Prep
ProQuest Central Student
ProQuest Central Essentials
elibrary
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
New England Journal of Medicine
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Research Library
ProQuest Public Health
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest Family Health
ProQuest One Academic Eastern Edition
British Nursing Index with Full Text
ProQuest Health Management
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
ProQuest One Academic
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
ProQuest One Psychology

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1533-4406
EndPage 1395
ExternalDocumentID oai_swepub_ki_se_541357
oai_prod_swepub_kib_ki_se_123398500
2486656381
10_1056_NEJMoa1103283
21995386
24615731
NJ201110133651508
Genre Original Article
Research Support, U.S. Gov't, Non-P.H.S
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: Wellcome Trust
  grantid: 077012/Z/05/Z
– fundername: Wellcome Trust
– fundername: Wellcome Trust
  grantid: 088340
– fundername: NCI NIH HHS
  grantid: R01 CA124929-05
– fundername: Wellcome Trust
  grantid: WT088340MA
– fundername: Medical Research Council
  grantid: MC_U105161083
– fundername: NCI NIH HHS
  grantid: P01 CA078378-10
– fundername: Wellcome Trust
  grantid: 093867
– fundername: Medical Research Council
  grantid: G0800784
– fundername: NCI NIH HHS
  grantid: P01 CA078378
– fundername: Wellcome Trust :
  grantid: 093867 || WT
GroupedDBID -
0R
0WA
123
186
1AW
1KJ
1VV
29N
2KS
2WC
34G
39C
3O-
3V.
4
4.4
53G
55
5D0
5RE
68V
7FN
7RV
7X7
85S
8AO
8C1
8FE
8FH
8FI
8RP
AACLI
AAEJM
AAIKC
AALRV
AAPBV
AAQQT
AARDX
AASXA
AAWTL
ABACO
ABEHJ
ABFLS
ABIVO
ABOCM
ABPPZ
ABPTK
ABQES
ABQIJ
ABUFD
ABUWG
ABWJO
ACGFS
ACGOD
ACJLH
ACNCT
ACPRK
ACRZS
ACVYA
ADBBV
ADCBC
AENEX
AETEA
AFDAS
AFFNX
AFHKK
AFKRA
AGNAY
AHMBA
AHVBC
AIKQT
AJJEV
AJYGW
ALMA_UNASSIGNED_HOLDINGS
AN0
AQUVI
AZQEC
BBAFP
BBNVY
BCR
BCU
BENPR
BES
BHPHI
BKEYQ
BKNYI
BLC
BNQBC
BPHCQ
BVXVI
C45
CJ0
CO
CS3
DCD
DU5
DWQXO
DZ
EBS
EJD
ET
EX3
F20
F5P
FD8
FM.
FYUFA
G8K
GJ
GNUQQ
GUQSH
H13
HCIFZ
HZ
IH2
K-O
K78
KM
KOO
L7B
LK8
M0R
M0T
M1P
M2M
M2O
M2P
M7P
MBDVC
MVM
N9A
NEJ
O0-
O9-
OK1
OMK
OVD
P-O
P2P
PADUT
PCD
PEA
PQEST
PQQKQ
PQUKI
PRINS
PROAC
PSQYO
QJJ
RHI
RWL
RXW
S10
S6N
SJFOW
SJN
TAE
TAF
TN5
TWZ
U1N
UCV
UKR
UMD
UQL
VQA
W2G
WH7
WOQ
WOW
X
X7M
XJT
XYN
XZL
YCJ
YNT
YRY
YZZ
ZA5
ZHY
ZKB
ZR0
ZXP
---
-DZ
-ET
-~X
.-4
.55
.CO
.GJ
08R
0R~
1CY
36B
41~
6TJ
8WZ
9M8
A6W
AAJWC
AAMNW
AAUGY
AAUTI
AAYOK
ABCQX
ABEFU
ACKOT
ACPFK
ACPVT
ACTDY
ADRHT
AFFDN
AFMIJ
AFOSN
AGFXO
AGHSJ
AJUXI
AKALU
CCPQU
D0S
FA8
HF~
HZ~
I4R
IQODW
J5H
MQT
N4W
NAPCQ
NHB
OHT
PSYQQ
QZG
SKT
TEORI
TUQ
UBX
UKHRP
WHG
XOL
YFH
YHZ
YQI
YQJ
YR2
YYP
YYQ
ZCA
ZGI
ZVN
~KM
ABBLC
ADUKH
AERZD
ALIPV
CGR
CUY
CVF
ECM
EIF
NPM
UIG
AAYXX
CITATION
0TZ
7XB
BEC
K0Y
Q9U
7X8
ABDPE
5PM
AAQOH
ABJNI
ADTPV
AOWAS
D8T
HMCUK
LPU
ZZAVC
ID FETCH-LOGICAL-c522t-ea100ec72a6e16319e9ae934ed4658c206216804298c60b6de85ab0288790efc3
IEDL.DBID 7X7
ISSN 0028-4793
1533-4406
IngestDate Thu Oct 31 04:30:29 EDT 2024
Wed Oct 30 05:00:02 EDT 2024
Tue Sep 17 21:14:44 EDT 2024
Fri Oct 25 23:32:39 EDT 2024
Thu Oct 10 16:51:13 EDT 2024
Thu Sep 26 15:51:34 EDT 2024
Sat Sep 28 08:22:27 EDT 2024
Sun Oct 22 16:05:54 EDT 2023
Wed Nov 11 00:31:23 EST 2020
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 15
Keywords Somatic mutation
Medicine
Ring
Malignant hemopathy
Sideroblast
Myelodysplastic syndrome
Cancer
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c522t-ea100ec72a6e16319e9ae934ed4658c206216804298c60b6de85ab0288790efc3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://kipublications.ki.se/Default.aspx?queryparsed=id:123398500
PMID 21995386
PQID 898517850
PQPubID 40644
PageCount 12
ParticipantIDs swepub_primary_oai_swepub_ki_se_541357
swepub_primary_oai_prod_swepub_kib_ki_se_123398500
pubmedcentral_primary_oai_pubmedcentral_nih_gov_3322589
proquest_miscellaneous_900626404
proquest_journals_898517850
crossref_primary_10_1056_NEJMoa1103283
pubmed_primary_21995386
pascalfrancis_primary_24615731
mms_nejm_10_1056_NEJMoa1103283
ProviderPackageCode DCD
7FN
PublicationCentury 2000
PublicationDate 2011-10-13
PublicationDateYYYYMMDD 2011-10-13
PublicationDate_xml – month: 10
  year: 2011
  text: 2011-10-13
  day: 13
PublicationDecade 2010
PublicationPlace Waltham, MA
PublicationPlace_xml – name: Waltham, MA
– name: United States
– name: Boston
PublicationTitle The New England journal of medicine
PublicationTitleAlternate N Engl J Med
PublicationYear 2011
Publisher Massachusetts Medical Society
Publisher_xml – name: Massachusetts Medical Society
References Langemeijer, SM, Kuiper, RP, Berends, M (r007) 2009; 41
Notta, F, Mullighan, CG, Wang, JC (r024) 2011; 469
Golas, MM, Sander, B, Will, CL, Luhrmann, R, Stark, H (r030) 2003; 300
Tefferi, A, Vardiman, JW (r001) 2009; 361
Ernst, T, Chase, AJ, Score, J (r010) 2010; 42
Golas, MM, Sander, B, Will, CL, Luhrmann, R, Stark, H (r031) 2005; 17
Pellagatti, A, Jadersten, M, Forsblom, AM (r003) 2007; 104
Finn, RD, Mistry, J, Tate, J (r032) 2010; 38
Fischer, A, Greenman, C, Mustonen, V (r033) 2011; 188
Chen, M, Manley, JL (r029) 2009; 10
Camaschella, C (r013) 2009; 46
Grand, FH, Hidalgo-Curtis, CE, Ernst, T (r004) 2009; 113
Walter, MJ, Ding, L, Shen, D (r027) 2011; 25
Sanada, M, Suzuki, T, Shih, LY (r005) 2009; 460
Navarro, I, Ruiz, MA, Cabello, A (r012) 2006; 30
Ley, TJ, Ding, L, Walter, MJ (r026) 2010; 363
Subramanian, A, Tamayo, P, Mootha, VK (r035) 2005; 102
Vardiman, JW, Thiele, J, Arber, DA (r011) 2009; 114
Boultwood, J, Pellagatti, A, Nikpour, M (r014) 2008; 3
Wang, C, Chua, K, Seghezzi, W, Lees, E, Gozani, O, Reed, R (r034) 1998; 12
Chapman, MA, Lawrence, MS, Keats, JJ (r037) 2011; 471
Ewalt, M, Galili, NG, Mumtaz, M (r025) 2011; 1
Anderson, K, Lutz, C, van Delft, FW (r022) 2011; 469
Varela, I, Tarpey, P, Raine, K (r016) 2011; 469
Ebert, BL, Pretz, J, Bosco, J (r002) 2008; 451
Ding, L, Ellis, MJ, Li, S (r021) 2010; 464
Tehranchi, R, Invernizzi, R, Grandien, A (r036) 2005; 106
Delhommeau, F, Dupont, S, Della Valle, V (r006) 2009; 360
Campbell, PJ, Pleasance, ED, Stephens, PJ (r017) 2008; 105
Gelsi-Boyer, V, Trouplin, V, Adelaide, J (r009) 2009; 145
Greenman, C, Stephens, P, Smith, R (r019) 2007; 446
Pellagatti, A, Cazzola, M, Giagounidis, AA (r015) 2006; 108
Bignell, GR, Greenman, CD, Davies, H (r028) 2010; 463
Malcovati, L, Porta, MG, Pascutto, C (r038) 2005; 23
Pellagatti, A, Cazzola, M, Giagounidis, A (r018) 2010; 24
Boultwood, J, Perry, J, Pellagatti, A (r008) 2010; 24
Jones, S, Zhang, X, Parsons, DW (r020) 2008; 321
Campbell, PJ, Yachida, S, Mudie, LJ (r023) 2010; 467
22014568 - Cancer Cell. 2011 Oct 18;20(4):420-3
r020
r021
r022
r001
r023
r017
r018
r019
r013
r035
r014
r036
r015
r037
r016
r038
r031
r010
r032
r011
r033
r012
r034
r030
r006
r028
r007
r008
r009
r002
r024
r003
r025
r004
r026
Chen M (r029) 2009; 10
r005
r027
References_xml – volume: 469
  start-page: 539
  year: 2011
  end-page: 542
  ident: r016
  article-title: Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma.
  publication-title: Nature
  contributor:
    fullname: Raine, K
– volume: 3
  start-page: e1970
  year: 2008
  end-page: e1970
  ident: r014
  article-title: The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts.
  publication-title: PLoS ONE
  contributor:
    fullname: Nikpour, M
– volume: 108
  start-page: 337
  year: 2006
  end-page: 345
  ident: r015
  article-title: Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.
  publication-title: Blood
  contributor:
    fullname: Giagounidis, AA
– volume: 25
  start-page: 1153
  year: 2011
  end-page: 1158
  ident: r027
  article-title: Recurrent DNMT3A mutations in patients with myelodysplastic syndromes.
  publication-title: Leukemia
  contributor:
    fullname: Shen, D
– volume: 451
  start-page: 335
  year: 2008
  end-page: 339
  ident: r002
  article-title: Identification of RPS14 as a 5q- syndrome gene by RNA interference screen.
  publication-title: Nature
  contributor:
    fullname: Bosco, J
– volume: 24
  start-page: 1062
  year: 2010
  end-page: 1065
  ident: r008
  article-title: Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia.
  publication-title: Leukemia
  contributor:
    fullname: Pellagatti, A
– volume: 105
  start-page: 13081
  year: 2008
  end-page: 13086
  ident: r017
  article-title: Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing.
  publication-title: Proc Natl Acad Sci U S A
  contributor:
    fullname: Stephens, PJ
– volume: 361
  start-page: 1872
  year: 2009
  end-page: 1885
  ident: r001
  article-title: Myelodysplastic syndromes.
  publication-title: N Engl J Med
  contributor:
    fullname: Vardiman, JW
– volume: 113
  start-page: 6182
  year: 2009
  end-page: 6192
  ident: r004
  article-title: Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms.
  publication-title: Blood
  contributor:
    fullname: Ernst, T
– volume: 469
  start-page: 356
  year: 2011
  end-page: 361
  ident: r022
  article-title: Genetic variegation of clonal architecture and propagating cells in leukaemia.
  publication-title: Nature
  contributor:
    fullname: van Delft, FW
– volume: 300
  start-page: 980
  year: 2003
  end-page: 984
  ident: r030
  article-title: Molecular architecture of the multiprotein splicing factor SF3b.
  publication-title: Science
  contributor:
    fullname: Stark, H
– volume: 41
  start-page: 838
  year: 2009
  end-page: 842
  ident: r007
  article-title: Acquired mutations in TET2 are common in myelodysplastic syndromes.
  publication-title: Nat Genet
  contributor:
    fullname: Berends, M
– volume: 46
  start-page: 371
  year: 2009
  end-page: 377
  ident: r013
  article-title: Hereditary sideroblastic anemias: pathophysiology, diagnosis, and treatment.
  publication-title: Semin Hematol
  contributor:
    fullname: Camaschella, C
– volume: 363
  start-page: 2424
  year: 2010
  end-page: 2433
  ident: r026
  article-title: DNMT3A mutations in acute myeloid leukemia.
  publication-title: N Engl J Med
  contributor:
    fullname: Walter, MJ
– volume: 114
  start-page: 937
  year: 2009
  end-page: 951
  ident: r011
  article-title: The 2008 revision of the WHO classification of myeloid neoplasms and acute leukemia: rationale and important changes.
  publication-title: Blood
  contributor:
    fullname: Arber, DA
– volume: 464
  start-page: 999
  year: 2010
  end-page: 1005
  ident: r021
  article-title: Genome remodelling in a basal-like breast cancer metastasis and xenograft.
  publication-title: Nature
  contributor:
    fullname: Li, S
– volume: 145
  start-page: 788
  year: 2009
  end-page: 800
  ident: r009
  article-title: Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia.
  publication-title: Br J Haematol
  contributor:
    fullname: Adelaide, J
– volume: 102
  start-page: 15545
  year: 2005
  end-page: 15550
  ident: r035
  article-title: Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.
  publication-title: Proc Natl Acad Sci U S A
  contributor:
    fullname: Mootha, VK
– volume: 467
  start-page: 1109
  year: 2010
  end-page: 1113
  ident: r023
  article-title: The patterns and dynamics of genomic instability in metastatic pancreatic cancer.
  publication-title: Nature
  contributor:
    fullname: Mudie, LJ
– volume: 24
  start-page: 756
  year: 2010
  end-page: 764
  ident: r018
  article-title: Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells.
  publication-title: Leukemia
  contributor:
    fullname: Giagounidis, A
– volume: 446
  start-page: 153
  year: 2007
  end-page: 158
  ident: r019
  article-title: Patterns of somatic mutation in human cancer genomes.
  publication-title: Nature
  contributor:
    fullname: Smith, R
– volume: 23
  start-page: 7594
  year: 2005
  end-page: 7603
  ident: r038
  article-title: Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making.
  publication-title: J Clin Oncol
  contributor:
    fullname: Pascutto, C
– volume: 188
  start-page: 383
  year: 2011
  end-page: 393
  ident: r033
  article-title: Germline fitness-based scoring of cancer mutations.
  publication-title: Genetics
  contributor:
    fullname: Mustonen, V
– volume: 360
  start-page: 2289
  year: 2009
  end-page: 2301
  ident: r006
  article-title: Mutation in TET2 in myeloid cancers.
  publication-title: N Engl J Med
  contributor:
    fullname: Della Valle, V
– volume: 30
  start-page: 971
  year: 2006
  end-page: 977
  ident: r012
  article-title: Classification and scoring systems in myelodysplastic syndromes: a retrospective analysis of 311 patients.
  publication-title: Leuk Res
  contributor:
    fullname: Cabello, A
– volume: 463
  start-page: 893
  year: 2010
  end-page: 898
  ident: r028
  article-title: Signatures of mutation and selection in the cancer genome.
  publication-title: Nature
  contributor:
    fullname: Davies, H
– volume: 460
  start-page: 904
  year: 2009
  end-page: 908
  ident: r005
  article-title: Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms.
  publication-title: Nature
  contributor:
    fullname: Shih, LY
– volume: 471
  start-page: 467
  year: 2011
  end-page: 472
  ident: r037
  article-title: Initial genome sequencing and analysis of multiple myeloma.
  publication-title: Nature
  contributor:
    fullname: Keats, JJ
– volume: 469
  start-page: 362
  year: 2011
  end-page: 367
  ident: r024
  article-title: Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells.
  publication-title: Nature
  contributor:
    fullname: Wang, JC
– volume: 104
  start-page: 11406
  year: 2007
  end-page: 11411
  ident: r003
  article-title: Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q- syndrome patients.
  publication-title: Proc Natl Acad Sci U S A
  contributor:
    fullname: Forsblom, AM
– volume: 12
  start-page: 1409
  year: 1998
  end-page: 1414
  ident: r034
  article-title: Phosphorylation of spliceosomal protein SAP 155 coupled with splicing catalysis.
  publication-title: Genes Dev
  contributor:
    fullname: Reed, R
– volume: 42
  start-page: 722
  year: 2010
  end-page: 726
  ident: r010
  article-title: Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders.
  publication-title: Nat Genet
  contributor:
    fullname: Score, J
– volume: 38
  start-page: D211
  year: 2010
  end-page: D222
  ident: r032
  article-title: The Pfam protein families database.
  publication-title: Nucleic Acids Res
  contributor:
    fullname: Tate, J
– volume: 106
  start-page: 247
  year: 2005
  end-page: 253
  ident: r036
  article-title: Aberrant mitochondrial iron distribution and maturation arrest characterize early erythroid precursors in low-risk myelodysplastic syndromes.
  publication-title: Blood
  contributor:
    fullname: Grandien, A
– volume: 17
  start-page: 869
  year: 2005
  end-page: 883
  ident: r031
  article-title: Major conformational change in the complex SF3b upon integration into the spliceosomal U11/U12 di-snRNP as revealed by electron cryomicroscopy.
  publication-title: Mol Cell
  contributor:
    fullname: Stark, H
– volume: 1
  start-page: e9
  year: 2011
  end-page: e9
  ident: r025
  article-title: DNMT3a mutations in high-risk myelodysplastic syndrome parallel those found in acute myeloid leukemia.
  publication-title: Blood Cancer J
  contributor:
    fullname: Mumtaz, M
– volume: 321
  start-page: 1801
  year: 2008
  end-page: 1806
  ident: r020
  article-title: Core signaling pathways in human pancreatic cancers revealed by global genomic analyses.
  publication-title: Science
  contributor:
    fullname: Parsons, DW
– volume: 10
  start-page: 741
  year: 2009
  end-page: 754
  ident: r029
  article-title: Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches.
  publication-title: Nat Rev Mol Cell Biol
  contributor:
    fullname: Manley, JL
– ident: r001
  doi: 10.1056/NEJMra0902908
– ident: r006
  doi: 10.1056/NEJMoa0810069
– ident: r019
  doi: 10.1038/nature05610
– ident: r014
  doi: 10.1371/journal.pone.0001970
– ident: r017
  doi: 10.1073/pnas.0801523105
– ident: r035
  doi: 10.1073/pnas.0506580102
– ident: r007
  doi: 10.1038/ng.391
– ident: r015
  doi: 10.1182/blood-2005-12-4769
– ident: r016
  doi: 10.1038/nature09639
– ident: r003
  doi: 10.1073/pnas.0610477104
– ident: r011
  doi: 10.1182/blood-2009-03-209262
– ident: r022
  doi: 10.1038/nature09650
– ident: r008
  doi: 10.1038/leu.2010.20
– ident: r024
  doi: 10.1038/nature09733
– ident: r020
  doi: 10.1126/science.1164368
– ident: r036
  doi: 10.1182/blood-2004-12-4649
– ident: r013
  doi: 10.1053/j.seminhematol.2009.07.001
– ident: r030
  doi: 10.1126/science.1084155
– ident: r031
  doi: 10.1016/j.molcel.2005.02.016
– ident: r023
  doi: 10.1038/nature09460
– ident: r033
  doi: 10.1534/genetics.111.127480
– ident: r034
  doi: 10.1101/gad.12.10.1409
– ident: r002
  doi: 10.1038/nature06494
– ident: r005
  doi: 10.1038/nature08240
– ident: r026
  doi: 10.1056/NEJMoa1005143
– ident: r010
  doi: 10.1038/ng.621
– ident: r038
  doi: 10.1200/JCO.2005.01.7038
– ident: r025
  doi: 10.1038/bcj.2011.7
– ident: r028
  doi: 10.1038/nature08768
– ident: r004
  doi: 10.1182/blood-2008-12-194548
– ident: r027
  doi: 10.1038/leu.2011.44
– ident: r021
  doi: 10.1038/nature08989
– ident: r012
  doi: 10.1016/j.leukres.2005.11.015
– volume: 10
  start-page: 741
  year: 2009
  ident: r029
  publication-title: Nat Rev Mol Cell Biol
  doi: 10.1038/nrm2777
  contributor:
    fullname: Chen M
– ident: r009
  doi: 10.1111/j.1365-2141.2009.07697.x
– ident: r037
  doi: 10.1038/nature09837
– ident: r032
  doi: 10.1093/nar/gkp985
– ident: r018
  doi: 10.1038/leu.2010.31
SSID ssj0000149
Score 2.6270294
Snippet Abnormalities in a gene encoding a messenger RNA splicing enzyme were found in nearly two thirds of patients with myelodysplastic syndromes characterized by...
Myelodysplastic syndromes are a diverse and common group of chronic hematologic cancers. The identification of new genetic lesions could facilitate new...
BackgroundMyelodysplastic syndromes are a diverse and common group of chronic hematologic cancers. The identification of new genetic lesions could facilitate...
BACKGROUNDMyelodysplastic syndromes are a diverse and common group of chronic hematologic cancers. The identification of new genetic lesions could facilitate...
SourceID swepub
pubmedcentral
proquest
crossref
pubmed
pascalfrancis
mms
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 1384
SubjectTerms Biological and medical sciences
Bone marrow
Deoxyribonucleic acid
DNA
Erythrocytes - pathology
Exons
Gene Expression Profiling
General aspects
Genetic testing
Genomes
Hematologic and hematopoietic diseases
High-Throughput Nucleotide Sequencing
Humans
Leukemia
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
Medical sciences
Medicin och hälsovetenskap
Mitochondria
mRNA
Mutation
Myelodysplastic syndrome
Myelodysplastic syndromes
Myelodysplastic Syndromes - genetics
Pathogenesis
Phenotype
Phosphoproteins - genetics
Point Mutation
Ribonucleoprotein, U2 Small Nuclear - genetics
RNA Splicing Factors
Sideroblasts
Splicing factors
Statistical analysis
Title Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts
URI http://dx.doi.org/10.1056/NEJMoa1103283
https://www.ncbi.nlm.nih.gov/pubmed/21995386
https://www.proquest.com/docview/898517850
https://search.proquest.com/docview/900626404
https://pubmed.ncbi.nlm.nih.gov/PMC3322589
http://kipublications.ki.se/Default.aspx?queryparsed=id:123398500
Volume 365
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Nb5wwELWaRKp6iZp-krQrH6rcUGwwxpyqJsoqirRRlTTS3ixjG3WbLmzL7iH_vjPgpUVNcoADGAQztufZM_OGkE_SwBpAOhkXTJoY7G0RG1lYWPMIzqyoKqMwwXl2JS9uxeU8m4fYnDaEVW7nxG6ido3FPfITVWAVeZWxz6tfMRaNQudqqKCxQ_Z4An0XunM-z_9hjwroN2wgBYpNMPknWGi-Mbxjk0tHJmlnuWwxQNK0IKOqL27xEPr8P4hyRDXamafpS7IfcCX90neEA_LM16_I81nwnL8GUN505Kz0Zpqecjrb9C54uqjp7N7_bNx9u-oyKinuzNJrsGj0BlP0mhIur9s35HZ6_u3sIg7FE2ILkGode8MZ8zZPjPSAuXjhkYY7Fd4JAB02YTLhUqE5UlayUjqvMlOCqFReMF_Z9C3ZrZvavyc0cZXiJheOOyUy60GtnFUeZsmySBInI3K8lZ9e9RwZuvNtZ1KPBB2RCUhX1_7H8tEGI8EPr0PWuyxPeUSOtprQYbC1eugaEaHDXRgl6PowtW82rS4wV1QKJiLyrlfb31djknqq4C_ykUKHBkjAPb5TL753RNwpzoaqiEjSq378CBhAHa7fLfDQrdcAFFL4XAbfevzAQ0N7bJsBwMjywyd_-Yi8SEJUIk8_kN31743_CDBpXU66wQBndcYnZO_0_Orr9R9s7RJ8
link.rule.ids 230,315,783,787,888,12070,12237,21402,27938,27939,31733,31734,33280,33281,33758,33759,43324,43593,43819,74081,74350,74638
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELZokaAXxJtQKD6g3qLaeTj2CQFitUDTA22lvVmO7YgFNtmS3UP_PTOJNxBROOTi2FEyE3s-e2a-IeS1MLAHEE7EigkTg71VsRHKwp4n48xmdW0kJjiXZ2J-mX1a5IsQm9OFsMrdmtgv1K61eEZ-IhVWkZc5e7O-irFoFDpXQwWNPXIbabiQOr9YFH-wRwX0Gw6QAsUmmPwTLDTfGt6zyaUTk7S3WnUYIGk6kFE9FLe4CX3-HUQ5oRrtzdPsPrkXcCV9O_wID8gt3zwkd8rgOX8EoLztyVnp-Sx9x2m5HVzwdNnQ8tr_aN11t-4zKimezNIvYNHoOabotRU0b7rH5HL24eL9PA7FE2ILkGoTe8MZ87ZIjPCAubjySMOdZt5lADpswkTChURzJK1glXBe5qYCUclCMV_b9AnZb9rGPyM0cbXkpsgcdzLLrQe1clZ7WCUrlSROROR4Jz-9HjgydO_bzoWeCDoiRyBd3fhvq392mAh-fByy3uVFyiNyuNOEDpOt0-OvERE63oVZgq4P0_h222mFuaIiY1lEng5q-_1oTFJPJXxFMVHo2AEJuKd3muXXnog7xdVQqogkg-qnQ8AA6tD-fYmX7rwGoJDC6zJ41-MbBo39sW8OACMvnv_3k1-Ru_OL8lSffjz7fEgOkhChyNMXZH_zc-tfAmTaVEf9xPgFc_ITBQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELZokSouVXmHQvEB9RatndiOfapKYVUeWyFKpd4sJ3HUBTbZkt1D_31nEm8gonDIxbGjZCb2fPbMfEPIG-VgD6BKFRumXAz21sROmQL2PIKzQlSV05jgPDtTpxfi46W8DJRCbQir3KyJ3UJdNgWekU-0wSryWrJJFaIivrybHi2vYywghY7WUE1ji9wHoyixioM-4X8wSQUkHA6TAt0mmP8JFp1vHO-Y5dKRedpaLFoMlnQtyKvqC13chUT_Dqgc0Y52pmq6R3YDxqTH_U_xkNzz9SOyMwte9McA0JuOqJWeT9O3nM7WvTuezms6u_E_m_KmXXbZlRRPaelXsG70HNP1mhyaV-0TcjF9_-3kNA6FFOIC4NUq9o4z5ossccoD_uLGIyV3KnwpAIAUCVMJVxpNky4Uy1XptXQ5iEpnhvmqSJ-S7bqp_XNCk7LS3GWi5KUWsvCgYs4qDytmbpKkVBE53MjPLnu-DNv5uaWyI0FH5ACka2v_ffHPDiPBD49DBjyZpTwi-xtN2DDxWjv8JhGhw12YMegGcbVv1q01mDeqBBMRedar7fejMWE91fAV2UihQwck4x7fqedXHSl3iiujNhFJetWPh4AxtKH9xxwv23oLoCGF12Xwrod3DBr6Y18JYENmL_77ya_JDswJ-_nD2ad98iAJwYo8fUm2V7_W_hWgp1V-0M2LWyIbFwU
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Somatic+SF3B1+Mutation+in+Myelodysplasia+with+Ring+Sideroblasts&rft.jtitle=The+New+England+journal+of+medicine&rft.au=Papaemmanuil%2C+E&rft.au=Cazzola%2C+M&rft.au=Boultwood%2C+J&rft.au=Malcovati%2C+L&rft.date=2011-10-13&rft.pub=Massachusetts+Medical+Society&rft.issn=0028-4793&rft.eissn=1533-4406&rft.volume=365&rft.issue=15&rft.spage=1384&rft.epage=1395&rft_id=info:doi/10.1056%2FNEJMoa1103283&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=2486656381
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0028-4793&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0028-4793&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0028-4793&client=summon